Nutra Pharma Corp NPHC:OTCPK

RT Quote | Exchange | USD
Last | 05/13/22 EDT
0.001UNCH (UNCH)
52 week range
0.00 - 0.01
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.001
  • 52 Week High0.01
  • 52 Week High Date07/26/21
  • 52 Week Low0.00
  • 52 Week Low Date08/30/21

Key Stats

  • Market Cap7.36M
  • Shares Out7.364B
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta2.62
  • YTD % Change-50

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.001
  • 52 Week High0.01
  • 52 Week High Date07/26/21
  • 52 Week Low0.00
  • 52 Week Low Date08/30/21
  • Market Cap7.36M
  • Shares Out7.364B
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta2.62
  • YTD % Change-50

RATIOS/PROFITABILITY

  • EPS (TTM)-0.00
  • P/E (TTM)-0.34
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-1.979M
  • ROE (TTM)-
  • Revenue (TTM)100,000.00
  • Gross Margin (TTM)8.68%
  • Net Margin (TTM)-13,398.32%
  • Debt To Equity (MRQ)-39.84%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nutra Pharma Corp

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Nutra Pharma Corp. is a holding company, which owns intellectual property and operates in the biotechnology industry. The Company conducts drug discovery research and development activities on its own and through its subsidiary, ReceptoPharm, Inc. Its first consumer product, Cobroxin, is an over-the-counter pain reliever designed to treat moderate to severe chronic pain. Its second consumer product, Nyloxin, an over-the-counter pain reliever that is a stronger version of...
Rik Deitsch
Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer
Address
12538 W Atlantic Blvd
Coral Springs, FL
33071-4085
United States